A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses

Abstract Vaccination is considered to be one of the most effective tools to decrease morbidity as well as mortality caused by influenza viruses. For the prevention of seasonal influenza, Fluarix ™ and FluLaval™ have been marketed since 1987 and 1992, respectively. Both vaccines have consistently bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Baras, Benoit, Bouveret, Nancy, Devaster, Jeanne‐Marie, Fries, Louis, Gillard, Paul, Sänger, Roland, Hanon, Emmanuel
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710798/
https://www.ncbi.nlm.nih.gov/pubmed/19453402
http://dx.doi.org/10.1111/j.1750-2659.2008.00054.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710798/
https://www.ncbi.nlm.nih.gov/pubmed/19453402
http://dx.doi.org/10.1111/j.1750-2659.2008.00054.x

Ejemplares similares